Nia Therapeutics
Nia Therapeutics is a clinical-stage biotechnology company focused on developing a groundbreaking brain-computer interface technology. They are creating the world's first brain stimulation therapy designed to treat memory loss, particularly in individuals with traumatic brain injury. Their "Smart Neurostimulation System" utilizes AI-guided, personalized neurostimulation delivered via a neural implant and an external processor. The system listens to unique brain activity patterns to deliver customized stimulation when memory loss is suspected, aiming to rescue memory-associated brain networks. The company was founded in 2018 and plans to start enrolling its first clinical trial in 2026, with the device aiming to be competitively priced and eventually covered by insurance. Their technology has been featured in publications like The New York Times and Scientific American.
Nia Therapeutics
Nia Therapeutics is a clinical-stage biotechnology company focused on developing a groundbreaking brain-computer interface technology. They are creating the world's first brain stimulation therapy designed to treat memory loss, particularly in individuals with traumatic brain injury. Their "Smart Neurostimulation System" utilizes AI-guided, personalized neurostimulation delivered via a neural implant and an external processor. The system listens to unique brain activity patterns to deliver customized stimulation when memory loss is suspected, aiming to rescue memory-associated brain networks. The company was founded in 2018 and plans to start enrolling its first clinical trial in 2026, with the device aiming to be competitively priced and eventually covered by insurance. Their technology has been featured in publications like The New York Times and Scientific American.